Comparative molecular field analysis of haptens docked to the multispecific antibody IgE(Lb4)

Journal of Medicinal Chemistry

Volumn 39, Issue 20, 1996, Pages 3882-3888

  Gamper, Armin M ^a,b   Winger, Rudolf H ^a   Liedl, Klaus R ^a   Sotriffer, Christoph A ^a   Varga, Janos M ^a   Kroemer, Romano T ^c   Rode, Bernd M ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HAPTEN; HYDROGEN; IMMUNOGLOBULIN E;

ANTIBODY SPECIFICITY; ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; INTERMETHOD COMPARISON; LIGAND BINDING; STRUCTURE ACTIVITY RELATION;

ANTIBODIES, MONOCLONAL; ANTIGENS; COMPUTER SIMULATION; HAPTENS; HYDROGEN BONDING; IMMUNOGLOBULIN E; MODELS, MOLECULAR; MOLECULAR STRUCTURE; STRUCTURE-ACTIVITY RELATIONSHIP; TRYPTOPHAN; TYROSINE;

EID: 0029838106     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm960229i     Document Type: Article

References (31)

1. Talmage, D. W. Immunological specificity. Science 1959, 129, 1643-1645.
2. Richards, F. F.; Konigsberg, W. H.; Rosenstein, R. W.; Varga, J. M. On the specificity of antibodies: biochemical and biophysical evidence indicates the existence of polyfunctional antibody combining regions. Science 1975, 187, 130-137.
3. Varga, J. M.; Konigsberg, W. H.; Richards, F. F. Antibodies with multiple binding functions. Induction of single immunoglobulin species by structurally dissimilar haptens. Proc. Natl. Acad. Sci. U.S.A. 1973, 70, 3269-3274.
4. Imanishi, T.; Makela, O. Inheritance of antibody specificity -I. Anti-(4-hydroxy-3-nitrophenyl)acetyl of the mouse primary response. J. Exp. Med. 1974, 140, 1498-1510.
5. Rudolph, A. K.; Burrows, P. D.; Wahl, M. R. Thirteen hybridomas secreting hapten-specific immunoglobulin E from mice with Iga and Igb heavy chain haplotype. Eur. J. Immunol. 1981,11,527-529.
6. Furusawa, S.; Ovary, Z. Heteroclitic antibodies: difference in fine specificity between monoclonal antibodies directed against dinitrophenyl and trinitrophenyl hapten. Int. Arch. Allergy Appl. Immunol. 1988, 85, 238-243.
7. Varga, J. M.; Kalchschmid, G.; Klein, G.; Fritsch, P. Mechanism of allergic cross-reactions -I. Multispecific binding of ligands to a mouse monoclonal anti-DNP IgE antibody. Mol. Immunol. 1991, 28, 641-654.
8. Kofler, H.; Schnegg, I.; Geley, S.; Helmberg, A.; Varga, J. M.; Kofler, R. Mechanism of allergic cross-reactions - III. cDNA cloning and variable region sequence analysis of two IgE antibodies specific for trinitrophenyl. Mol. Immunol. 1992, 29, 161-166.
9. Droupadi, P. R.; Varga, J. M.; Linthicum, D. S. Mechanism of allergenic cross-reactions - IV. Evidence for participation of aromatic residues in the ligand binding site of two multi-specific IgE monoclonal antibodies. Mol. Immunol. 1994, 31, 537-548.
10. Winger, R. H.; Liedl, K. R.; Sotriffer, C. A.; Camper, A. H.; Kroemer, R. T.; Rode, B. M.; Varga, J. M. Prediction of antibody-ligand complex structures by automated docking - Binding of small molecules to a mouse monoclonal IgE antibody. J. Mol. Recognit., in press.
11. Goodsell, D. S.; Olson A. J. Automated Docking of Substrates to Proteins by Simulated Annealing. PROTEINS: Struct. Funct., Genet. 1990, 8, 195-202.
12. Cramer, R. D. III; Patterson, D. E.; Bunce, J. D. Comparative Molecular Field Analysis (CoMFA). 1. Effect of Shape on Binding of Steroids to Carrier Proteins. J. Am. Chem. Soc. 1988, 110, 5959-5967
13. Wold, S.; Albano, C.; Dunn W. J.; Edlund, U.; Esbenson, K.; Geladi, P.; Hellberg, S.; Lindberg, W.; Sjöström, M. In Chemometrics: Mathematics and Statistics in Chemistry; Kowalski, B., Ed.; Reidel: Dordrecht, The Netherlands, 1984; pp 17-95.
14. Dunn, W. J.; Wold, S.; Edlund, U.; Hellberg, S.; Gasteiger, J. Multivariate Structure-Activity Relationship Between Data from a Battery of Biological Tests and an Ensemble of Structure Descriptors: The PLS Method. Quant. Struct.-Act. Relat. 1984, 5, 131-137.
15. Geladi, P. Notes on the History and Nature of Partial Least Squares (PLS) Modelling. J. Chemomet. 1988, 2, 231-246.
16. Cramer, R. D., III; Bunce, J. D.; Patterson, D. E. Crossvalidation, Bootstrapping and Partial Least Squares Compared with Multiple Regression in Conventional QSAR Studies. Quant. Struct.-Act. Relat. 1988, 7, 18-25.
17. Marshall, G. R.; Barry, C. D.; Bosshard, H. E.; Dammkoehler, R. A.; Dunn, D. A. The conformational parameters in drug design. In Computer-Assisted Drug Design; Olson, E. C., Christoffersen, R. E., Eds.; ACS Symp. Series No. 112, American Chemical Society: Washington, DC, 1979; pp 205-226.
18. Droupadi, P. R.; Anchim, J. M.; Meyers, E. A.; Linthicum, D. S. Spectrofluorometric study of the intermolecular complexation of monoclonal antibodies with the high potency sweetener N-(p-cyanophenyl)-N'-(diphenylmethyl)guanidineacetic acid. J. Mol. Recognit. 1993, 5, 173-179.
19. The program SYBYL 6.0 is available from Tripos Assoc., 1699 S. Hanley Rd., St. Louis, MO 63144.
20. Dewar, M. J. S.; Zoebisch, E. G.; Healy, E. F.; Stewart, J. J. P. AM1: A New General Purpose Quantum Chemical Mechanical Molecular Model. J. Am. Chem. Soc. 1985, 107, 3902-3909.
21. The program MOPAC 6.0 is available from Quantum Chemistry Program Exchange No. 455.
22. Clark, M.; Cramer, R. D., III; Van Opdenbosch, N. Validation of the general purpose Tripos 5.2 force field. J. Comput. Chem. 1989, 10, 982-1012.
23. Kroemer, R. T.; Hecht, P. Replacement of steric 6-12 potential-derived interaction energies by atom-based indicator variables in CoMFA leads to models of higher consistency. J. Comput.-Aided Mol Design. 1995, 9, 205-212.
24. Clark, M.; Cramer, R. D. III. The probability of chance correlation using Partial Least Squares (PLS). Quant. Struct.-Act. Relat. 1993, 12, 137-145.
25. Debnath, A. K.; Jiang, S.; Strick, N.; Lin, K.; Haberfield, P.; Neurath, A. R. Three-Dimensional Structure-Activity Analysis of a Series of Porphyrin Derivatives with Anti-HIV-1 Activity Targeted to the V3 Loop of the gp120 Envelope Glycoprotein of the Human Immunodeficiency Virus Type 1. J. Med. Chem. 1994,37, 1099-1108.
26. Avery, M. A.; Gao, F.; Chong W. K. M.; Mehrotra S.; Milhous, W. K. Structure-Activity Relationships of the Antimalarial Agent Artemisinin. 1. Synthesis and Comparative Molecular Field Analysis of C-9 Analogs of Artemisinin and 10-Deoxoartemisinin. J. Med. Chem. 1993, 36, 4264-4275.
27. Carroll, F. I.; Mascarella, S. W.; Kuzemko, M. A.; Gao, Y.; Abraham, P.; Lewin, A. H.; Boja, J. W.; Kuhar, M. J. Synthesis, Ligand Binding, and QSAR (CoMFA and Classical) Study of 3β-(3′-Substituted phenyl)-, 3β-(4′-Substituted phenyl)-, and 3β-(3′,4′-Disubstituted phenyl)tropane-2β-carboxylic Acid Methyl Esters. J. Med. Chem. 1994, 37, 2865-2873.
28. Tong, W.; Collantes, E. R.; Chen, Y.; Welsh, W. J. A Comparative Molecular-Field Analysis Study of N-Benzylpiperidines as Acetylcholesterinesterase Inhibitors. J. Med. Chem. 1996, 39, 380-387.
29. Kroemer, R. T.; Ettmayer, P.; Hecht, P. 3D-Quantitative Structure-Activity Relationships of Human Immunodeficiency Virus Type-1 Proteinase Inhibitors: Comparative Molecular Field Analysis of 2-Heterosubstituted Statine Derivatives-Implications for the Design of Novel Inhibitors. J. Med. Chem. 1995,38,4917-4928.
30. Waller, C. L.; Oprea, T. I.; Giolitti, A.; Marshall, G. R. Three-Dimensional QSAR of Human Immunodeficiency Virus (I) Protease Inhibitors. 1. A CoMFA Study Employing Experimentally-Determined Alignment Rules. J. Med. Chem. 1993, 36, 4152-4160.
31. Mian, I. S.; Bradwell, A. R.; Olson, A. J. Structure, Function and Properties of Antibody-Binding Sites. J. Mol. Biol. 1991, 217, 133-151.